Cover - shares
|
3 Months Ended |
|
Mar. 31, 2020 |
Apr. 30, 2020 |
| Cover [Abstract] |
|
|
| Document Type |
10-Q/A
|
|
| Amendment Flag |
false
|
|
| Document Quarterly Report |
true
|
|
| Document Transition Report |
false
|
|
| Document Period End Date |
Mar. 31, 2020
|
|
| Document Fiscal Period Focus |
Q1
|
|
| Document Fiscal Year Focus |
2020
|
|
| Current Fiscal Year End Date |
--12-31
|
|
| Entity File Number |
001-38586
|
|
| Entity Registrant Name |
RUBIUS THERAPEUTICS, INC.
|
|
| Entity Central Index Key |
0001709401
|
|
| Entity Tax Identification Number |
46-2688109
|
|
| Entity Incorporation, State or Country Code |
DE
|
|
| Entity Address, Address Line One |
399 Binney Street
|
|
| Entity Address, Address Line Two |
Suite 300
|
|
| Entity Address, City or Town |
Cambridge
|
|
| Entity Address, State or Province |
MA
|
|
| Entity Address, Postal Zip Code |
02139
|
|
| City Area Code |
617
|
|
| Local Phone Number |
679-9600
|
|
| Title of 12(b) Security |
Common Stock, par value $0.001 per share
|
|
| Trading Symbol |
RUBY
|
|
| Security Exchange Name |
NASDAQ
|
|
| Entity Current Reporting Status |
Yes
|
|
| Entity Interactive Data Current |
Yes
|
|
| Entity Filer Category |
Accelerated Filer
|
|
| Entity Small Business |
true
|
|
| Entity Emerging Growth Company |
true
|
|
| Elected Not To Use the Extended Transition Period |
false
|
|
| Entity Shell Company |
false
|
|
| Entity Common Stock, Shares Outstanding |
|
80,476,102
|